🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Kapoor et al. reported that stereotactic body radiation therapy (SBRT) is promising for treating hepatocellular carcinoma (HCC), in patients unfit for surgery, with a local control rate of 66.7% and median overall survival of 28 months. Read more: bit.ly/4fHgXd1

Bijalwan et al. discuss the challenges of glioblastoma multiforme (GBM), noting its aggressive nature and high recurrence rates. They emphasize current treatments and innovative strategies like immunotherapy, urging ongoing research to enhance outcomes. bit.ly/3YiMJG0

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors, and publishers for your contribution. Read here: bit.ly/3Kf29px Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #oncology #CancerResearch #MedTwitter

Dr. Lal and team highlight the potential of low-dose regorafenib for mCRC. With a median PFS of 9.2 months and mean OS of 39.2 months, findings underscore its efficacy, safety at 80 mg/day, and need for personalized treatment. Read here: bit.ly/3W7o0E6 #CRST #MedTwitter

Yadav et al. found that 75.5% of lung cancer cases in Nepal were NSCLC, with 97% diagnosed at an advanced stage. Notably, 67.7% were non-smokers, stressing the need for early detection and targeted interventions. Read here: bit.ly/3X91v26 #NSCLC #CancerResearch #Nepal

A study on endometrial cancer in Northwest India reports a 5-year OS of 85.6%, but high-risk cases had a 4-year OS of 37.6%. Findings highlight the need for tailored treatment, especially for high-risk patients. Read here: bit.ly/4kTECdF#Oncolo… #EndometrialCancer #MedTwitter

A study by Basu et al. reports successful implementation of NGS and qRT-PCR for cancer diagnostics in rural Bihar. Despite challenges, this initiative advances precision medicine access in resource-limited settings. Read here: bit.ly/4hlWryS #CRST #MedTwitter #Oncology

Majumdar and team report key predictors of pENE in OSCC—bone invasion, perineural invasion, and nodal characteristics—emphasizing the role of histopathology in treatment decisions. Read more: bit.ly/4iigqzQ #OralCancer #Oncology #MedTwitter #CRST

A study on security personnel at AIIMS, New Delhi finds 29% have oral premalignant lesions. Smokeless tobacco users face a higher risk than smokers. Visual screening and tobacco cessation are key to prevention. Read more: bit.ly/4iiYtkH #OralCancer #MedTwitter #CRST

Dr. Lakshmi et al. discuss ctDNA’s role in colorectal cancer for early detection, personalized treatment, and monitoring. Advances in ctDNA tech could transform CRC care. Read more: bit.ly/4iDG5mm #Oncology #ColorectalCancer #MedTwitter #CRST

Mohamed et al. discuss the role of gut microbiota in breast cancer initiation, progression, and treatment response. Manipulating commensal gut bacteria could offer new therapeutic strategies. Read more: bit.ly/4iHRTEd #BreastCancer #GutMicrobiome #CRST #MedTwitter

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors, and publishers for your contribution. Read here: bit.ly/3Kf29px Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #Oncology #CancerResearch #MedTwitter

A study by Vallath et al. describes how NCG, India used A3 methodology to enhance QI education, increasing satisfaction from 6.6 to 8.7/10 and boosting trainee and mentor confidence. Read more: bit.ly/4jKyV0p #CRST #MedTwitter #QualityImprovement #CancerCare

A recent multicenter study confirms the safety of nivolumab in Indian patients with NSCLC and RCC. Among 100 participants, 25% experienced treatment-related AEs, mostly low grade, with no SAEs in the RCC group. Read more: bit.ly/4k4e88t #Nivolumab #OncologyIndia #CRST

Krishnamurthy et al. present a health-economic comparison of chemoports vs. PICCs in Indian cancer care. Chemoports showed up to 65% cost savings, supporting broader use for long-term chemo. Read more: bit.ly/42PeglZ #CancerCare #Chemoports #PICC #CRST #MedTwitter

Maheshwari et al. report alarmingly low cervical cancer screening among married Indian women—only 1.9%. Wealth, education, and region were key predictors, highlighting need for targeted, equitable action. Read more: bit.ly/4keDhwN #CervicalCancer #NFHS5 #CRST #MedTwitter

Darling et al. report a 40.9% prevalence of PIK3CA mutations in Indian patients with breast cancer — above global rates. Linked to HER2+ status, high nodal burden & advanced disease, supporting targeted therapy use. Read more: bit.ly/4jM08A1 #Cancer #PIK3CA #MedTwitter

Sekaran et al.'s meta-analysis of 15 RCTs (n = 1,148) shows structured exercise (strength, balance, cardio) improves symptoms and quality of life in patients with paclitaxel-induced neuropathy—without adverse effects. Read more: bit.ly/4jO2myK #Oncology #CRST #MedTwitter

Kumar et al. present a comprehensive review on FLT3 in AML—covering its biology, detection, and therapy. With FLT3 inhibitors reshaping treatment, this review highlights key insights and gaps. Read more: bit.ly/3ERvRk1 #AML #FLT3 #Hematology #Oncology #CRST #MedTwitter

Our new issue is live! Looking forward to your comments and criticism. Sincere thanks to all authors, reviewers, editors, and publishers for their contribution. Read here: bit.ly/3Kf29px Vanita Noronha, MBBS MD DM Tata Memorial Hospital #CRST #Oncology #CancerResearch #MedTwitter